Cormorant Asset Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,165,000
Closed -$49.1M 61
2023
Q4
$49.1M Sell
1,165,000
-60,000
-5% -$2.21M 2.35% 8
2023
Q3
$47M Buy
1,225,000
+675,000
+123% +$15.3M 2.74% 10
2023
Q2
$10.4M Buy
+550,000
New +$10.3M 0.59% 38
2023
Q1
Sell
-400,000
Closed -$7.1M 79
2022
Q4
$7.1M Buy
+400,000
New +$5.04M 0.48% 44
2021
Q2
Sell
-337,048
Closed -$5.41M 115
2021
Q1
$5.41M Sell
337,048
-1,225,904
-78% -$32.3M 0.16% 91
2020
Q4
$72.2M Sell
1,562,952
-74,999
-5% -$3.47M 2.1% 20
2020
Q3
$57.6M Buy
+1,637,951
New +$49.3M 2.54% 11

Other funds holding IMVT